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Abstract
Human T-cell leukemia virus type 1 (HTLV-1) is the causal agent of a neoplastic disease of CD4
+ T cells, adult T-cell leukemia
(ATL), and inflammatory diseases including HTLV-1 associated myelopathy/tropical spastic paraparesis, dermatitis, and
inflammatory lung diseases. ATL cells, which constitutively express CD25, resemble CD25
+CD4
+ regulatory T cells (Treg).
Approximately 60% of ATL cases indeed harbor leukemic cells that express FoxP3, a key transcription factor for Treg cells.
HTLV-1 encodes an antisense transcript, HTLV-1 bZIP factor (HBZ), which is expressed in all ATL cases. In this study, we show
that transgenic expression of HBZ in CD4
+ T cells induced T-cell lymphomas and systemic inflammation in mice, resembling
diseases observed in HTLV-1 infected individuals. In HBZ-transgenic mice, CD4
+Foxp3
+ Treg cells and effector/memory CD4
+
T cells increased in vivo. As a mechanism of increased Treg cells, HBZ expression directly induced Foxp3 gene transcription in
T cells. The increased CD4
+Foxp3
+ Treg cells in HBZ transgenic mice were functionally impaired while their proliferation was
enhanced. HBZ could physically interact with Foxp3 and NFAT, thereby impairing the suppressive function of Treg cells.
Thus, the expression of HBZ in CD4
+ T cells is a key mechanism of HTLV-1-induced neoplastic and inflammatory diseases.
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Introduction
Human T-cell leukemia virus type 1 (HTLV-1) was the first
human retrovirus associated with human diseases including adult
T-cell leukemia (ATL) [1,2] and HTLV-1 associated myelopathy/
tropical spastic paraparesis (HAM/TSP)[3,4]. One of the
virological attributes of HTLV-1 is that it transmits mainly by
cell-to-cell contact [5,6]. Therefore, HTLV-1 induces the
proliferation of infected CD4
+ T cells to increase further
transmission [7]. HTLV-1 encodes several regulatory and
accessory genes in the pX region located between the env gene
and the 39 LTR [7,8]. Among the viral genes, tax possesses in vitro
transforming activity and can induce cancers in transgenic (Tg)
animals via its pleiotropic actions [9,10]. Yet the expression of Tax
is frequently disrupted in ATL [7]. In contrast, the HTLV-1 bZIP
factor (HBZ) gene, which is encoded in the minus strand of the
HTLV-1 genome [11,12], is transcribed in all ATL cases [13].
Recently, it has been reported that APOBEC3G generates
nonsense mutations in all HTLV-1 genes except HBZ [14],
suggesting that the HBZ gene is indispensable for the growth and/
or survival of ATL cells and HTLV-1 infected cells. The HBZ
gene product promotes the proliferation of ATL cells [13,15].
Further, HBZ mRNA expression in HAM/TSP patients was well
correlated with disease severity [16]. These findings suggest that
HBZ has a critical role in the development of ATL and HAM/
TSP.
It has been shown that ATL cells functionally and phenotyp-
ically resemble Foxp3
+ CD25
+CD4
+ regulatory T (Treg) cells,
which control immune responses against self- and non-self-antigen
[17]. ATL cells constitutively express CD25 and scarcely produce
interleukin-2 (IL-2)[18,19]. Furthermore, two thirds of ATL cases
harbor leukemic cells expressing FoxP3 [20,21], a key transcrip-
tion factor for the generation and function of Treg cells [22,23,24].
In HTLV-1 carriers, HTLV-1 provirus is detected mainly in
CD4
+ effector/memory T cells and Treg cells [25,26,27]. Thus,
HTLV-1 favors Treg cells and effector/memory T cells in vivo, and
transforms them. However, how HTLV-1 targets these T cell
subpopulations remains to be elucidated.
In this study, we show that transgenic expression of HBZ
increases Foxp3
+ Treg cells and effector/memory T cells, leading
to development of T-cell lymphomas and systemic inflammatory
diseases. In addition, the suppressive function of Treg cells is
severely impaired in HBZ transgenic mice. At the molecular level,
we show that HBZ interacts with Foxp3 and NFAT, interrupting
the function of each molecule, and leading to the deregulation of
Foxp3-mediated transcriptional control of the genes associated
PLoS Pathogens | www.plospathogens.org 1 February 2011 | Volume 7 | Issue 2 | e1001274with Treg functions. These results indicate that HBZ plays a critical
role in neoplastic and inflammatory diseases arising from HTLV-1
infection.
Results
HBZ transgenic mice spontaneously develop
inflammatory lesions in the skin and lung
Since HTLV-1 mainly infects CD4
+ T cells in vivo, we generated
Tg mice expressing the HBZ gene under the control of the murine
CD4-specific promoter/enhancer/silencer (Figure S1) [13]. We
analyzed the HBZ transgenes (Figure S1) and their expression in
the three lines generated. HBZ gene expression was specifically
detected in CD4
+ T cells (Figure 1A). HBZ protein was also
detected in these transgenic mice (Figure 1B). The level of HBZ
gene transcripts in line 12 was the most abundant but similar to
that of endogenous expression of the HBZ gene in ATL cell lines
(Figure 1C). Therefore, unless specifically described, we used line
12 in this study. Notably, the majority of HBZ-Tg mice developed
skin lesions by 18 weeks of age, in contrast with no disease in non-
transgenic littermates (non-Tg mice) (Figure 1, D and E).
Histological analyses revealed infiltration of CD3
+CD4
+ T cells
into the dermis and epidermis, and also the alveolar septa of the
lung (Figure 1, F, G and S2), whereas no obvious evidence of
inflammation in other tissues, including liver, kidney, muscle,
heart, stomach, spinal cord, intestines and brain. Since massive
infiltration of lymphocytes in the skin and lung was observed in
line 9 and 12, but not in line 2, level of HBZ expression is likely
associated with these phenotypes. Thus, HBZ-Tg mice spontane-
ously developed dermatitis and alveolitis. Similar lesions have been
observed in HTLV-1 carriers, especially in those harboring large
numbers of infected cells [28,29].
HBZ-Tg mice develop T-cell lymphoma after a long latent
period
To study the growth-promoting activity of the HBZ gene, we
assessed the proliferation of CD4
+ T cells in HBZ-Tg mice by
incorporation of bromodeoxyuridine (BrdU), and found that the
proliferation was three fold-higher than in non-Tg mice, whereas
the proliferation of CD8
+ T cells or B cells was not altered
(Figure 2A, Table S1A). Transgenic expression of HBZ enhances
the in vivo proliferation of mouse T cells, as ectopic expression of
HBZ enhances the proliferation of human T cells [13,15]. It is
known that HTLV-1 transforms CD4
+ T cells after a long latent
period in a fraction of asymptomatic carriers [7]. Analogous to the
development of ATL in humans, 14 of 37 (37.8%) HBZ-Tg mice
of all three-founder lines developed T-cell lymphomas after 16
months, in contrast with 2 of 27 non-Tg mice (7.4%) (P,0.001 by
the logrank test) (Figure 2B). In some transgenic mice, lymphoma
cells infiltrated various organs including the lung, bone marrow,
spleen and liver (Figure 2C). All of the lymphomas in HBZ-Tg
mice were CD3
+ and CD4
+ by immunohistochemical analyses
when examined before the mice became moribund (Figure 2D).
Lymphoma cells also expressed abT cell receptors on their
surfaces (Figure S3). Monoclonal proliferation of these lymphoma
cells was shown by single strand conformation polymorphism in
Vc2-Jc1 junction region of T cell receptor cchain gene (Figure
S4). Notably, the primary lymphoma cells expressed Foxp3 at
various intensities in the majority of cases (Figure 2E, Table 1),
exhibiting a similar FoxP3 staining pattern to that in lymph nodes
in human ATL cases (Figure S5). Thus, the T-cell lymphomas in
HBZ-Tg mice phenotypically resemble ATL, suggesting that HBZ
promotes proliferation of CD4
+ T cells and predisposes expressing
cells to transform in due course.
Increased effector/memory and regulatory CD4
+ T cells in
HBZ-Tg mice
To study the cellular basis of the lymphomagenesis and
inflammation in HBZ-Tg mice, we analyzed the phenotype and
function of T cells, especially Treg cells, in 3-month-old HBZ-Tg
line 12 mice before their pathological manifestations. CD44
high
CD62L
low effector/memory CD4
+ T cells increased in HBZ-Tg
mice (Figure 3A). CD4 single positive T cells also increased in the
thymus (Figure S6). Further, not only the ratio but also the
absolute number of Foxp3
+ T cells was markedly increased in
HBZ-Tg mice compared with non-Tg mice, while the numbers of
Foxp3
2 T cells were equivalent (Figure 3, B and C). Increased Treg
cells were also observed in thymus, lymph node and peripheral
blood mononuclear cells (Figure 3D and Figure S7). We also
observed the increased Treg cells and effector/memory T cells in
the HBZ-Tg line 2 (Figure S8), which showed quite lower
expression of HBZ than line 12 (Figure 1C). The proportion of
Treg cells in skin and lung was rather low compared with that in
spleen (Figure 3B and S2), indicating that Foxp3
2 T cells are
predominant in the infiltrating T cells.
This result indicates that transgenic expression of HBZ induces
systemic inflammation despite an increase in Foxp3
+ Treg cells. It
has been reported that IL-2 is critical in the homeostasis of Treg
cells [30]. To study mechanisms by which HBZ expression
increases Treg cells, we analyzed IL-2 production in the CD4
+ T
cells of HBZ-Tg mice after stimulation by PMA and ionomycin.
IL-2 production was not augmented in either the Foxp3
+ or
Foxp3
2 populations from HBZ-Tg mice (Figure S9), indicating
that the increase in the number of Treg cells was not due to
enhanced IL-2 production.
Previous studies showed that Tax is a critical viral protein for
the pathogenesis of HTLV-1. Therefore, we generated Tax
transgenic (tax-Tg) mice using the same promoter/enhancer/
silencer. In the tax-Tg mice, we did not observe increased effector/
memory T cells or Treg cells (Figure S10). Thus, this increase in
effector/memory T cells and Treg cells was specific to HBZ and
Author Summary
Human T-cell leukemia virus type 1 (HTLV-1) is the first
retrovirus that is associated with human diseases including
an aggressive leukemia derived from CD4
+ T cells, adult T-
cell leukemia (ATL), and chronic inflammatory diseases of
the central nervous system, lung, or skin. However, it
remains to be elucidated how HTLV-1 induces these
diseases. A viral gene, tax, has been considered as a critical
player in HTLV-1 pathogenesis, yet Tax expression is
frequently lost in ATL cells. Another viral gene, HBZ,i s
constitutively expressed in both HTLV-1 infected cells and
ATL cells. However, it remains unknown how HBZ
functions in the HTLV-1-related diseases. We show here
that the HBZ induced T-cell lymphoma and chronic
inflammation in vivo similar to those in HTLV-1 infected
individuals, indicating an important role of HBZ in HTLV-1
associated human diseases. As observed in HTLV-1
infected individuals, effector/memory and regulatory
CD4
+ T cells were increased in the HBZ-transgenic mice.
Further, HBZ could interact with host transcription factors,
Foxp3 and NFAT, leading to dysregulation of Treg function.
The Treg dysregulation induced by HBZ is thought to be a
critical mechanism of the HTLV-1 pathogenesis. This study
sheds light on the HTLV-1 associated pathogenesis and
provides an important clue to prevent or treat the human
diseases.
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transgenic model system.
We next analyzed the phenotype and function of the increased
Foxp3
+ Treg cells in HBZ-Tg mice. CD4
+Foxp3
+ T cells of HBZ-
Tg mice expressed Treg-associated molecules, such as cytotoxic T-
lymphocyte associated antigen-4 (CTLA-4), glucocorticoid-in-
duced TNF receptor family-related-protein (GITR), CD103, and
CD25 [31]; yet the expression levels of CTLA-4, GITR and CD25
were lower than those of Foxp3
+ T cells in non-Tg mice (Figure 3,
B and E, Table S1B). In contrast, both Foxp3
+ and Foxp3
2 CD4
+
T cells of HBZ-Tg mice expressed CCR4 and CD103 at higher
levels than those in non-Tg mice, suggesting that this might
contribute to the migration and infiltration of HBZ-Tg CD4
+ T
cells into the skin (Figure 1F) [32,33]. Further, it is of note that the
in vitro suppressive function of HBZ-Tg Treg cells was severely
impaired. When CD4
+GITR
high T cells, which were .90%
Foxp3
+ [23], from HBZ-Tg or non-Tg mice were co-cultured with
CD4
+CD25
2 T cells from wild-type mice and stimulated with
Con A or anti-CD3 antibody, HBZ-Tg Treg cells were much less
suppressive (Figure 3F). These results indicate that HBZ
expression increases functionally impaired Treg cells.
Next, we assessed the proliferation of CD4
+ Tc e l l si nHBZ-Tg
mice. BrdU incorporation of Foxp3
+ as well as Foxp3
2CD4
+ Tc e l l s
fromHBZ-Tgmice wasalsosignificantlyhigherthanthosein non-Tg
mice (Figure 3G). In general, proliferation of Treg cells in response to
mitogenic stimulation is suppressed in vitro. However, Foxp3
+ Tc e l l s
from HBZ- T gm i c ep r o l i f e r a t e dm o r ev i g o r o u s l yin vitro in response to
anti-CD3 antibody than did non-Tg Foxp3
+ T cells (Figure 3H).
Thus, transgenic expression of HBZ in CD4
+ T cells induces the
expansion of Foxp3
+ Treg cells, yet impairs their suppressive function.
Figure 1. HBZ-Tg mice spontaneously develop inflammatory diseases in skin and lung. (A) Cell-type specific transcription of the transgene
in line 12 was confirmed by RT-PCR in each sorted cell population. (B) The expression of HBZ protein in CD4
+ splenocytes was confirmed by Western
blotting. (C) Transcripts of the HBZ gene in CD4
+ splenocyte of HBZ-Tg mice or ATL cell lines were quantified by real time PCR. ATL-43T and MT-1 are
derived from ATL cells. (D) An HBZ-Tg mouse with typical skin symptom (Arrow indicates skin lesion). (E) The incidence of dermatitis in HBZ-Tg (line
12) and non-Tg mice. (F and G) Histological findings of the skin and the lung in HBZ-Tg mice. Lymphocytes massively infiltrated the dermis and
epidermis (F) and the alveolar septum (G) (Arrows present infiltration of lymphocytes). Infiltration of CD3
+, CD4
+ T cells into these tissues was shown
by immunohistochemistry compared with non-Tg mice as control.
doi:10.1371/journal.ppat.1001274.g001
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+ T-cell
intrinsic manner
To study whether HBZ increases Foxp3
+ Treg cells in a cell
intrinsic manner, we expressed HBZ in naive CD4
+ T cells in vitro
using a retrovirus vector (Figure 4A). Interestingly, HBZ induced
Foxp3 expression in 16.8% of HBZ expressing T cells, which is a
similar enhancement to that due to TGF-b treatment (14.8%).
The expression was markedly augmented in HBZ expressing T
cells treated with TGF-b (72.2%) (Figure 4B). A reporter assay
using the enhancer and promoter of the Foxp3 gene [34]
demonstrated that HBZ induced transcription of the Foxp3 gene
(Figure 4C), which was enhanced in the presence of TGF-b. Thus,
HBZ-induced Foxp3 expression could be a mechanism for the
increase of Foxp3
+ T cells in HBZ-Tg mice.
HBZ physically interacts with Foxp3
Previous studies have shown that Foxp3 controls Treg function
by cooperating with transcription factors including NFAT [35]
and AML-1/Runx1[36]. Impaired interactions of Foxp3 with
these factors not only alter the suppressive function of Treg cells but
also suppress the expression of Treg associated molecules, such as
CD25, CTLA-4, and GITR [23,35,36,37], which is similar to the
Figure 2. HBZ-Tg mice develop T-cell lymphoma after a long latent period. (A) BrdU was injected into mice twice a day for three days, and
splenocytes were stained with antibodies to BrdU, CD4, CD8, and B220. (B) Incidence of T-cell lymphoma in HBZ-Tg mice was statistically significant
compared with that in non-Tg mice (P,0.001 by the logrank test). (C) Pleomorphic lymphoma in the cervical lymph node in a representative HBZ-Tg
mouse. Infiltrations of lymphoma cells into lung, bone marrow, spleen and liver are also shown. (D) Expression of CD3 and CD4 in lymphoma cells was
shown by immunohistochemical staining. (E) Immunohistochemical staining for Foxp3 in primary lymphomas of HBZ-Tg mice.
doi:10.1371/journal.ppat.1001274.g002
HTLV-1 bZIP Factor Induced Pathogenesis
PLoS Pathogens | www.plospathogens.org 4 February 2011 | Volume 7 | Issue 2 | e1001274phenotype observed in HBZ-Tg mice (Figure 3, B and E). These
findings prompted us to assess the possibility that HBZ might be
involved in Foxp3-dependent transcriptional regulation. To
address this, we first examined direct interaction among HBZ,
NFAT and Foxp3. Immunoprecipitation experiments showed that
HBZ physically interacted with both NFAT and Foxp3
(Figure 5A). Moreover, to study the interaction of endogenous
HBZ and Foxp3, we performed immunoprecipitation using ATL-
43T, a Foxp3-expressing ATL cell line. An anti-HBZ antibody co-
precipitated endogenous Foxp3 in the ATL-43T cells, demon-
strating that the interaction occurs not only in an enforced over-
expressed state but also under physiological conditions (Figure 5B).
It has been previously reported that human FoxP3 protein
migrates as a doublet, which coincides with this result [38].
Analyses using HBZ deletion mutants showed that the central
domain of HBZ interacted with Foxp3 (Figure 5C). Experiments
with Foxp3 deletion mutants revealed that HBZ interacted with
the forkhead (FH) domain of Foxp3 (Figure 5D). It has been
reported that the region between the forkhead domain and the
leucine zipper domain of Foxp3 interacted with AML-1 [36]. HBZ
did not inhibit the binding between Foxp3 and AML-1 nor the
suppressive effect of Foxp3 on AML-1-mediated transcription
from the IL-2 gene promoter (Figure S11), indicating that HBZ
does not influence Foxp3/AML1 mediated gene regulation.
To study whether HBZ independently interacts with Foxp3 and
NFAT or, alternatively, if these molecules form a ternary complex,
we studied the effect of the DNA intercalator ethidium bromide
(EtBr) on their interactions. As shown in Figure 5E, the
interactions of HBZ with Foxp3 or NFAT were not affected by
EtBr while the interaction between NFAT and Foxp3 was
diminished by EtBr as reported previously [35]. These findings
suggest that the interactions of HBZ with NFAT and Foxp3 are
independent of DNA while the interaction between NFAT and
Foxp3 requires the presence of DNA.
HBZ inhibits Foxp3-mediated CTLA-4 and GITR
expression in CD4
+ T cells in vitro
In HBZ-Tg mice, the expression of Treg-associated molecules
including CTLA-4, GITR and CD25 was suppressed when
compared with their expression in Treg cells from non-Tg mice
(Figure 3B and E). This finding may account for the impaired
function of Treg cells since these molecules, in particular CTLA-4,
play a critical role in Treg-mediated suppression [39]. To further
study the effect of HBZ on the expression of Treg-associated
molecules, we transduced HBZ along with Foxp3 into naive CD4
+
T cells in vitro using retrovirus vectors (Figure 4A). HBZ expression
suppressed Foxp3-induced GITR and CTLA-4 expression where-
as it did not inhibit CD25 expression (Figure 6A). Expression of
HBZ alone increased CD25 expression (Figure 6A), which might
obscure the suppressive effect of HBZ under these conditions.
Suppression of GITR and CTLA-4 expression required both the
activation and the central domains of HBZ (Figure 6, B and C),
which correspond to the binding sites of HBZ to Foxp3 (Figure 5C)
and NFAT (Figure S12). Since both Foxp3 and NFAT are critical
Table 1. Characteristics of lymphomas in HBZ-Tg and non-Tg littermates.
Latency IHC
Genotype Strain ID (Months) B220 CD3 Foxp3 Phenotype
non-Tg 24 - - - non-T, non-B
(2/27) 24 + -- B
26 + -- B
13 - - - non-T, non-B
27 - ++ T
32 - ++ T
HBZ-Tg #211 1 - ++ +T
(14/37) (3/14) 2 19 - + -T
32 4 - ++ T
#912 3 ++ +T
(4/5) 2 18 ++ + + T
32 6 ++ +T
42 9 - ++ T
#12 1 23 - 6 ++ T
(7/18) 2 19 - ++ T
35 - + +++ T
41 0 - ++ +T
52 7 ++ -T
62 4 - 6 ++ T
71 8 - ++ T
Mice that died or became immobilized were subjected to autopsy. Tissue samples were surgically removed, fixed in 10% formalin in phosphate buffer, embedded in
paraffin and stained with hematoxylin and eosin for histopathological examination. Tissue samples with lymphoma were subjected to immunohistochemical analysis
(IHC) using monoclonal antibodies for CD3 (500A2), B220 (RA3-6B2), and Foxp3 (FJK-16s). The phenotype of lymphomas was determined based on CD3 and B220
expression. The degree of Foxp3 expression in lymphomas was evaluated by immunohistochemistry. (+, 1–9%; ++, 10–20%; +++, more than 20%) Frequency of T-cell
lymphoma of each line is shown as follows; (number of T-cell lymphoma/number of total observed mice).
doi:10.1371/journal.ppat.1001274.t001
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+ T cells increases Foxp3
+ Treg cells with impaired suppressive function. (A and B)
Mouse splenocytes were stained with the indicated antibodies, and analyzed by flow cytometry. Representative dot plots gated on the CD4
+
population are shown. For these experiments, HBZ-Tg mice without any symptoms were used. Tables show the mean 6 SD (n=5 for A, n=3 for B).
(C) The absolute number of Foxp3
+ or Foxp3
2 CD4
+ T cells in HBZ-Tg and non-Tg mice. The results shown are the mean 6 SD (n = 3). (D) Flow
cytometric analysis for the Foxp3 expression in CD4 single positive thymocytes. Representative dot plots gated on the CD4 single positive population
are shown from three independent analyses. (E) Flow cytometric analyses of CD4
+ T cells for Treg related molecules. Numbers in dot plots indicate
mean fluorescence intensity (MFI) of each molecule in the rectangular gates. (F) Suppressive activity of Treg cells from HBZ- or non-Tg mice on T-cell
proliferation. Sorted Foxp3
+ T cells were cultured with CD4
+CD25
2 cells of non-Tg mice as responder cells for 72 h with ConA or soluble anti-CD3
HTLV-1 bZIP Factor Induced Pathogenesis
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expression of GITR and CTLA-4 by interacting with Foxp3 and
NFAT and thereby interfering with their transcriptional regulation
in Treg cells. To examine suppressive effect of HBZ on expression
of GITR, CTLA-4 and CD25, we isolated Treg cells from wild
type mice and expressed HBZ using retroviral vectors. As shown in
Figure 6D, HBZ suppressed endogenous expression of CD25,
GITR and CTLA-4 in Treg cells, confirming that HBZ is
responsible for suppressed expression of these molecules.
Discussion
HTLV-1 targets CD4
+ T cells; cell central to immune
regulation. In contrast to human immunodeficiency virus, which
destroys CD4
+ T cells, HTLV-1 increases its copy number by
inducing clonal proliferation of infected cells in vivo [40,41]. Since
HTLV-1 spreads mainly by cell-to-cell transmission [5], increased
number of infected cells facilitates transmission of HTLV-1 to new
cells. Recent studies showed that glucose transporter 1, heparan
sulfate proteoglycans and neuropilin-1 are important for the entry
of HTLV-1[42,43,44], consistent with the finding that this virus
can infect a variety of cell types [45,46]. However, HTLV-1
provirus is detected mainly in the regulatory and effector/memory
CD4
+ T cells of HTLV-1 carriers (Figure S13) [25,26,27], which
indicates that HTLV-1 favors these specific subpopulations of
CD4
+ T cells. These findings suggest that HTLV-1 induces
proliferation and/or facilitates survival of the regulatory and
effector/memory CD4
+ T cells. The mechanism(s) by which
HTLV-1 targets Treg cells, however, remained unclear until now.
In this study, we showed that HBZ could enhance transcription of
the Foxp3 gene, and also promote proliferation of Foxp3
+CD4
+ T
cells in transgenic mice, indicating that HBZ enhances both the
generation and proliferation of Foxp3
+ T cells. Impaired Foxp3
function is associated with proliferation of Treg cells [37], so the
HBZ-mediated Treg dysfunction may also contribute to Treg
proliferation in addition to direct growth proliferation by the HBZ
transcript [13]. Another possible explanation is that Treg cells
might be more susceptible to HTLV-1 infection, since Treg cells
proliferate vigorously in vivo presumably by recognizing self-
antigen and commensal microbes [47]. With these strategies,
HTLV-1 likely targets this specific T-cell population as its host,
which might be beneficial for their survival.
As mechanisms of the HBZ-mediated effect on Foxp3
functions, we demonstrated that HBZ physically interacted with
Foxp3 and impaired its function in vitro. HBZ lacking the Foxp3-
binding region showed a slight inhibitory effect on Foxp3
function, indicating that direct interaction between HBZ and
Foxp3 is, at least in part, responsible for suppression. The results
of immunoprecipitation analyses using Foxp3 mutants showed
that the forkhead domain of Foxp3 was responsible for the
molecular interaction between HBZ and Foxp3. Since the
forkhead domain is the DNA-binding domain of Foxp3 [17],
HBZ might inhibit the transcriptional function of Foxp3 by
interfering with the DNA binding activity. Foxp3 play a key role
in the function and homeostasis of Treg cells [22,23,24],
indicating that HBZ-mediated dysfunction of Foxp3 contributes
to impaired Treg function in HBZ-Tg mice. This impaired Treg
function allows non-regulatory T cells to become hyper-reactive
to commensal microbes and self-antigens, provoking enhanced
proliferation of non-regulatory T cells and T cell-mediated
autoimmune/inflammatory disease. These data collectively
suggest that the viral protein HBZ hijacks the transcriptional
Figure 4. HBZ directly induces Foxp3 expression in CD4
+ T
cells. (A) Schematic diagrams of retrovirus vectors used in this study.
(B) Mouse CD4
+CD25
2 T cells transduced with retrovirus vector
encoding HBZ or empty vector with or without TGF-b were stained
with anti-Foxp3 antibody and analyzed by flow cytometry. (C) To study
the effect of HBZ on promoter activity of the Foxp3 gene, EL4 cells were
transfected with Foxp3 reporter plasmid and/or HBZ expressing
plasmid. Representative data shown are firefly luciferase activities
normalized to those of renilla luciferase (mean 6 SD).
doi:10.1371/journal.ppat.1001274.g004
antibody and x-irradiated antigen presenting cells (APCs), and [
3H] thymidine incorporation during the last 6 hours was measured. Results are means
6 SD for triplicate cultures. (G) In vivo BrdU incorporation in total CD4
+, Foxp3
+CD4
+, or Foxp3
2CD4
+ T cells. The results shown are the mean 6 SD
(n=3). (H) Sorted Foxp3
+ cells were labeled with CFSE and cultured with anti-CD3 antibody and x-irradiated APCs. After 96 hours, the cells were
stained with anti-Foxp3, and CFSE dilution was analyzed for Foxp3
+ cells. *, P,0.01; **, P,0.001 by two-tailed Student t-test.
doi:10.1371/journal.ppat.1001274.g003
HTLV-1 bZIP Factor Induced Pathogenesis
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the host. Conversely, Tax, another HTLV-1 protein, has been
reported to suppress FoxP3 expression in human T cells in vitro
[48]. Therefore, it is likely that both viral proteins target Foxp3
albeit with apparently different effects. Considering that HBZ is
consistently expressed while Tax expression is sporadic, Tax
might control excess expression of Foxp3 in HTLV-1 infected
cells.
Figure 5. HBZ physically interacts with Foxp3 and NFAT. (A) The expression vectors of the indicated proteins were co-transfected into 293FT
cells, and their interactions were analyzed by immunoprecipitation (IP). (B) Nuclear extract of ATL-43T cells was subjected to IP with anti-HBZ
antibody or control IgG, and detected by anti-FoxP3 antibody. (C and D) The interactions of HBZ and Foxp3 were analyzed by IP using HBZ mutants
(C) or Foxp3 mutants (D). A schematic diagram of Foxp3 mutants is shown. ZnF, zinc finger; LZ, leucine zipper; FH, forkhead domain. Asterisks (* or **)
show responsible region for each molecular interaction. (E) The interactions among HBZ, Foxp3 and NFATc2 were analyzed with or without EtBr.
doi:10.1371/journal.ppat.1001274.g005
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PLoS Pathogens | www.plospathogens.org 8 February 2011 | Volume 7 | Issue 2 | e1001274Figure 6. HBZ inhibites Foxp3-mediated CTLA-4 and GITR expression in vitro. (A) Mouse CD4
+CD25
2 T cells co-transduced with the
retroviral vectors were stained with the indicated antibodies. Mean fluorescence intensity (MFI) of CD25, GITR, and CTLA-4 in GFP/NGFR double-
positive cells are shown as mean 6 SD. for triplicate culture. *, P,0.01; **, P,0.001 by two-tailed Student t-test. (B and C) CD4
+CD25
2 T cells
transduced with the pMXs-Ig vector encoding wild-type or mutant HBZ, and pGCSamIN-Foxp3 vector were stained with anti-GITR (B) or anti-CTLA-4
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+
T cells in HBZ-Tg mice resemble those of human ATL cells or
HTLV-1 infected cells in carriers. First, the frequency of Foxp3
positive cells in T-cell lymphomas was similar in HBZ-Tg mice and
in ATL [20]. Second, the suppressive function of Foxp3
+ T cells
was impaired in both ATL and HBZ-Tg mice [49]. Third, CD4
+
T cells in HBZ-Tg mice, HTLV-1-infected cells in carriers, and
ATL cells possess similar effector/memory and regulatory
phenotypes [25,27]. As shown in this study, transgenic mice
expressing Tax under the same promoter as the HBZ-Tg mice did
not show any changes in the number of Foxp3
+ Treg cells or
effector/memory T cells. These data suggest that HBZ, rather
than Tax, is responsible for conferring the specific phenotype of
HTLV-1 infected cells and ATL cells.
It has been reported that tax transgenic animals develop tumors
[50,51,52]. In these reports, Tax induced tumors, the type of
which depends on the promoter used. However, irrespective of the
possible oncogenic activity of Tax, leukemic cells in ATL patients
frequently lose Tax expression [7], whereas HBZ expression has
been detected in all ATL cases studied so far [13]. We reported
that the HBZ gene transcript itself has growth-promoting activity
in vitro [13]. Taken together, our results suggest that HBZ is
responsible for the specific phenotype, function and proliferation
of HTLV-1-infected CD4
+ T cells and ATL cells, and that HBZ
plays important roles for the oncogenic activity of HTLV-1 in
addition to Tax. Further, the long latent period before the onset of
T-cell lymphomas in HBZ-Tg mice suggests that additional genetic
and/or epigenetic alterations in CD4
+ T cells are necessary for the
development of T-cell lymphomas in HBZ-Tg mice as well as for
ATL.
In conclusion, the HBZ-mediated dysregulation of Treg function
and proliferation that we report here provides novel insights into
the interaction between the host and the virus and may be
exploited to treat and prevent HTLV-1-induced diseases.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
Institutional Review Board of Kyoto University (E921). All
patients provided written informed consent for the collection of
samples and subsequent analysis. Animal experimentation was
performed in strict accordance with the Japanese animal welfare
bodies (Law No. 105 dated 19 October 1973 modified on 2 June
2006), and the Regulation on Animal Experimentation at Kyoto
University. The protocol was approved by the Institutional Animal
Research Committee of Kyoto University (Permit Number: D09-
3). All efforts were made to minimize suffering.
Mice and cell cultures
C57BL/6J mice were purchased from CLEA Japan. The HBZ
cDNA was cloned into the SalI site of the H/M/T-CD4 vector,
which was designed for restricted expression of a transgene in
CD4
+ cells. The purified fragment containing the HBZ transgene
was microinjected into C57BL/6J F1 fertilized eggs. Transgenic
founders were screened for the integration of transgenes in their
genomic DNA by PCR and mated with C57BL/6J mice to
generate transgenic progeny [13,15]. All HBZ-Tg mice were
heterozygotes for the transgene. The phenotype of HBZ-Tg mice
was stable in the different generations. They express the spliced
HBZ gene under the control of the CD4-specific promoter/
enhancer/silencer. All mice were used at 10-16 weeks of age unless
specifically described.
The human embryonic kidney cell line, 293FT, was cultured in
DMEM containing 10% FCS and G418 (500 mg/ml). The 293FT
cell line is derived from the 293F cell line and stably expresses the
SV40 large T antigen. 293FT cell line was purchased from
Invitrogen. The packaging cell line, Plat-E (kindly provided by T.
Kitamura, Tokyo University) was cultured in DMEM supple-
mented with 10% FCS containing 10 mg/ml blasticidin and 1 mg/
ml puromycin. ATL-43T(2) (kindly provided by M. Maeda,
Kyoto University) and MT-1 cells were derived from ATL cells,
and cultured in RPMI containing 10% FCS and antibiotics
(penicillin and streptomycin). A mouse T-cell lymphoma line, EL4
cells, were cultured with RPMI1640 containing 10% FCS,
antibiotics, and 50 mM 2-mercaptoethanol (2-ME; Invitrogen).
Plasmids
In order to construct the vectors expressing tagged spliced HBZ
and its mutants, their coding sequences were amplified by PCR,
and cloned into the expression vector, pcDNA 3.1(2)/myc-His
(Invitrogen). A cDNA clone that contains NFATc2 coding
sequence was kindly provided by Kazusa DNA Research Institute.
To construct the FLAG-tagged NFATc2 expression vector, its
coding region was cloned into pCMV-Tag2 (Stratagene). pCMV-
HA (Clontech) was used to generate HA-tagged Foxp3 expression
vectors. The vectors expressing Flag-tagged Foxp3 mutants were
also used for immunoprecipitation.
Antibodies and reagents
The following antibodies were used for immunoprecipitation
and Western blotting: mouse anti-Flag (clone M2; Sigma, Saint
Louis, MO), mouse anti-c-myc (clone 9E10; Sigma), mouse anti-
HA (clone HA-7; Sigma), rabbit anti-His polyclonal antibody
(MBL), rabbit anti-FOXP3 (polyclonal antibody; Abcam), and
rabbit anti-HBZ polyclonal antisera [15].
The following antibodies were purchased from BD PharMin-
gen; purified monoclonal antibody (mAb) for mouse CD4 (RM4-
5), CD8a (53-6.7), CD25 (PC61), CD44 (IM7), CD103 (M290),
and IL-2 (JES6-5H4). Purified monoclonal antibodies for mouse
GITR (DTA-1), CTLA-4 (UC10-4B9), CD62L (MEL-14), TCRb
(H57-597), TCRcd (eBioGL3) and Foxp3 (FJK-16s) or human
FoxP3 (236A/E7) were purchased from eBioscience. Anti-mouse
CCR4 antibody (polyclonal antibody; Capralogics) and FITC-
labeled anti-goat IgG antibody (Santa Cruz Biotechnology) were
used for the detection of mouse CCR4. The following reagents
were used for cell culture: anti-CD3e antibody (145-2C11; R&D
systems), Con A (Sigma), PMA (Sigma), and ionomycin (Sigma).
Synthesis of cDNA and semiquantitative RT-PCR
cDNAs were synthesized from 1 mg total RNA of purified
mouse CD4
+ T cells by a reverse transcriptase SuperScript III and
random primers according to the manufacturer’s instructions
(C) antibody in addition to anti-NGFR antibody, and then analyzed by flow cytometry. Left, numbers in density plots indicate MFI of GITR (B) or CTLA-4
(C) in GFP/NGFR double-positive cells. Representative data from three independent experiments are shown. Right, relative MFI of wild type or
mutated HBZ compared to mock transduced cells was shown as mean 6 SD (n=3). (D) HBZ transduction in Foxp3
+ Treg cells inhibited the
endogenous expression of Treg associated molecules. Mean fluorescence intensity (MFI) of CD25, GITR, and CTLA-4 in CD4
+Foxp3
+NGFR
+ cells are
shown as mean 6 SD. for triplicate culture. *, P,0.05; **, P,0.01 by two-tailed Student t-test.
doi:10.1371/journal.ppat.1001274.g006
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using RT-PCR. The primers used were as follows: sHBZ gene: 59-
TAAACTTACCTAGACGGCGG-39 (sense), 59-CTGCCGAT-
CACGATGCGTTT -39 (antisense); GAPDH gene: 59-GTG-
GAGA TTGTTGCCATCAACG -39 (sense) and 59-AGA-
GGGGCCATCCACAGTCTT-39 (antisense). PCR was per-
formed in a PC-808 (Astec) under the following conditions:
HBZ: 2 minutes at 95uC, followed by 26 cycles of 30 seconds at
95uC, 30 seconds at 59uC and 60 seconds at 72uC; GAPDH: 3
minutes at 95uC, followed by 35 cycles of 30 seconds at 95uC, 30
seconds at 61uC and 30 seconds at 72uC.
Quantitative RT-PCR
To quantify the expression level of HBZ, a TaqMan probe and
primers for HBZ were designed. The sequences of primers and
probe for HBZ were as follows; HBZ primers; 59-GGACG-
CAGTTCAGGAGGCAC-39 (sense) and 59-CCTCCAAGGA-
TAATAGCCCG-39 (antisense); HBZ probe; 59-CCTGT-
GCCATGCCCGGAGGACCTGC-39. We used the TaqMan
Gene expression Assay for 18S rRNA (Applied Biosystems) as an
internal control. Relative expression level of HBZ or IL-2 was
calculated with the delta delta Ct method.
Retroviral constructs and transduction
For retroviral gene transduction experiments, spliced HBZ
cDNA was cloned into a retroviral vector, pMXs-Ig (a gift from T.
Kitamura), to generate pMXs-Ig-HBZ. pGCSamIN (kindly
provided from M. Onodera) and pGCSamIN-Foxp3 were used
as previously described. Transfection of the packaging cell line,
Plat-E, was performed as described. For retroviral transduction,
CD25
2CD4
+ cells were enriched by a CD4 enrichment kit (BD
Pharmingen) and were activated by 0.5 mg/ml anti-CD3 Ab and
50 U/ml rIL-2 in the presence of T-cell-depleted and x-irradiated
(20Gy) C57BL/6J splenocytes as APCs in 12 well plates. After
16 hours, activated T cells were transduced with viral supernatant
and 4 mg/ml polybrene, and centrifuged at 3,000 rpm for 60 min.
Cells were cultured in medium supplemented with 50 U/ml rIL-2.
Activation of naı ¨ve T cells by anti-CD3 antibody influenced
expression of these molecules. Therefore, we analyzed their
expression after influence by activation was lost [35]. Two days
later, Foxp3-mediated CTLA-4 expression was detected by a flow
cytometry, and five days later, expression of GITR or CD25 was
analyzed. After two days, we stimulated the transduced cells with
50 ng/ml PMA and 1 mg/ml ionomycin in the presence of protein
transport inhibitor (BD PharMingen) for 6 hours, and then
analyzed intracellular IL-2 expression using intracellular cytokine
staining kits (BD Pharmingen) according to the manufacturer’s
instructions.
To elucidate the effect of HBZ on endogenous expression of
Treg associated molecules, we transduced HBZ into CD4
+Foxp3
+
cells purified from mouse splenocytes. Three days after transduc-
tion, the expression levels of Treg associated molecules were
evaluated by a flow cytometry.
Preparation of splenocytes, flow cytometric analyses, cell
sorting, and assays of regulatory T cells
Cell suspensions were prepared from murine spleens by forcing
the organs through a nylon mesh, and splenic erythrocytes were
eliminated with NH4Cl. Proliferation of murine cells was
measured by
3H-thymidine uptake after 3 days of incubation in
RPMI1640 medium supplemented with 10% FCS and 50 mM2 -
ME. Flow cytometric analyses and cell sorting were carried out
using a FACS CantoII or FACS Aria with Diva Software (BD
Pharmingen) and the data was analyzed by FlowJo software
(Treestar). For cell surface staining, 10
6 cells were incubated with
mAbs for 30 min at 4uC, and then analyzed. For intracellular
staining, we used a mouse Foxp3 staining kit according to its
protocol (eBioscience). To sort Foxp3
+ cells, suspended splenocytes
were stained with mAb for CD4 and GITR, and the
CD4
+GITR
high fraction was sorted by FACS Aria. Purity of the
sorted population was always .90% by re-analysis of Foxp3
staining. For the ex vivo proliferation assay of Foxp3
+ cells, carboxy-
fluorescein diacetate, succinimidyl ester (CFSE)(Molecular Probe)
was used according to the manufacturer’s instructions. Foxp3
+ T
cells (2610
4/well) were stimulated with anti-CD3 antibody (4 mg/
ml) in round-bottomed 96-well plates in the presence of x-
irradiated splenocytes as antigen presenting cells (APC; 5610
4/
well) for 96 hours. Then, cells were permeabilized, and stained
with anti-Foxp3. CFSE dilution was analyzed by flow cytometry.
To evaluate the suppressive activity of Foxp3
+ T cells sorted from
HBZ-Tg or non-Tg mice, Foxp3
+ T cells (2610
4/well) were
cultured with CD25
2CD4
+ cells (2610
4/well) and APCs (5610
4/
well) from wild-type mice for 72 h in the presence of soluble anti-
CD3 (4 mg/ml) or Con A (1 mg/ml), and then [
3H] thymidine
incorporation was measured.
BrdU staining
In vivo proliferation was measured by BrdU incorporation. BrdU
(Nacalai Tesque) was dissolved in PBS (3 mg/ml), and then 200 ml
was injected intraperitoneally into HBZ-Tg and non-transgenic
mice twice a day for three days as reported previously [53]. BrdU
incorporation in CD4
+, CD8
+, or B220
+ splenocytes was detected
using FITC BrdU Flow Kits (BD Pharmingen) according to the
manufacturer’s instructions. Flow cytometric analyses were
performed on a FACS CantoII with Diva Software (BD
Pharmingen).
Foxp3 reporter assay
We constructed Foxp3 promoter and enhancer reporter
plasmids as the previous report [34]. A murine T-cell line, EL4
cells (1610
7), were transiently cotransfected by electroporation
with the following plasmid DNAs: Foxp3 reporter plasmid, Renilla
luciferase control vector (pRL-TK), and HBZ expression vector
(pME18SneoHBZ). Cells were cultured with or without TGF-b
(2 ng/ml). Firefly and Renilla luciferase activities were measured
using the Dual-Luciferase Reporter Assay System (Promega).
Relative luciferase activities were calculated as the ratio of firefly
and Renilla luciferase activities. The luciferase values are shown as
relative values. Values represent means plus standard deviations
(error bars) (n=3).
Histological analyses
The study of clinical samples was approved by the local research
ethics committee of the appropriate hospital. Tissue samples were
fixed in 10% formalin in phosphate buffer and then embedded in
paraffin. Haematoxylin and eosin (H&E) staining was performed
according to standard procedures. Images were captured using a
Provis AX80 microscope (Olympus) equipped with OLYMPUS
DP70 digital camera, and detected using a DP manager system
(Olympus).
For analysis of tumors, mice that became immobilized were
sacrificed and subjected to autopsy. Tissue samples were surgically
removed and fixed in 10% formalin in phosphate buffer and
embedded in paraffin. Sections were stained with H&E for
histopathologic examination. After we obtained informed consent,
tissue samples from patients who were diagnosed as lymphoma-
type ATL were analyzed by immunohistochemical methods to
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CD3e(500A2; BD Pharmingen), B220 (RA3-6B2; BD Pharmin-
gen), and Foxp3 (FJK-16s; eBioscience) were used for immuno-
histochemistry. We judged CD3
+B220
+ cases to be T-cell
lymphomas since some activated T cells and T cells of the lpr/
lpr mutant mouse expressed B220 [54,55].
PCR/single stranded conformation polymorphism (SSCP)
analysis
To investigate clonality of lymphoma cells observed in HBZ-Tg
mice, lymphoma tissue samples of HBZ-Tg were analyzed for the
clonality of T-cell receptor (TCR) c locus using PCR-SSCP analysis
of the TCR c-gene. Genomic DNA was subjected to PCR
amplification using primers for the Vc2 gene and the Jc1. The
primers used were as follows: Vc2: 59-ACCAAGAGATGA-
GACTGCACAA-39 (sense), Jc1: 59-GCGTCTGATCCTCAAAA-
TAACTTCC-39 (antisense); PCR was performed in a PC-808
(Astec) under the following conditions: 3 minutes at 95uC, followed
by 35 cycles of 30 seconds at 95uC, 30 seconds at 55uCa n d3 0
seconds at 72uC. We used EL-4 as a positive control and splenic
DNA from young non-Tg or HBZ-Tg mice as negative control.
PCR products were run on a 6% polyacrylamide gel and visualized
by staining with DNA Silver Staining Kit (GE Healthcare).
Coimmunoprecipitation assay and immunoblotting
Expression vectors for the relevant genes were transiently
cotransfected into 293FT cells using the TransIT-LT1 reagent
(Mirus Bio). 24 hours later, transfected cells were stimulated with
50 ng/ml PMA and 1 mg/ml ionomycin for another 6 hours.
Coimmunoprecipitation assays were performed using the Nuclear
Complex Co-IP Kit (Active motif). Briefly, the nuclear extracts of
transfected cells were prepared in the presence or absence of
ethidium bromide (10 mg/ml). They were precleared with Protein
G Sepharose 4 Fast Flow (GE Healthcare), and their supernatants
were incubated with anti-myc tag (clone 9E10, Sigma) or anti-Flag
tag (M2, Sigma) antibody overnight at 4uC. The immunocom-
plexes were precipitated with Protein G Sepharose 4 Fast Flow,
fractionated in SDS-PAGE, and transferred to PVDF membranes.
HBZ-myc-His was detected with horseradish peroxidase (HRP)-
conjugated anti-His tag (MBL) antibody. HRP-conjugated anti-
Flag tag (Sigma) and anti-HA tag (Sigma) antibodies were used to
detect Flag-tagged and HA-tagged proteins, respectively. To
detect endogenous interaction between HBZ and FoxP3, immu-
noprecipitation was performed using an ATL cell line, ATL-43T
(-), as described above with anti-HBZ antisera and anti-FOXP3
antibody (Abcam). To examine the expression of HBZ in
transgenic mice, CD4
+ splenocytes from wild type or HBZ-Tg
mice were enriched by a mouse CD4 T lymphocyte enrichment
set (Pharmingen). Whole cell extracts were prepared with the lysis
buffer (50 mM Tris-HCL, PH 7.5, 150 mM NaCl, 1% NP-40),
and analyzed by western blotting with anti-HBZ antisera.
Flow cytometric analysis for HTLV-1 carrier cells
A previous report demonstrated that Tax expression could not be
detected in freshly isolated PBMC from HTLV-1 infected carriers
but could be detected when they were cultivated ex vivo for 12 hours
[56]. We cultured PBMCs from asymptomatic HTLV-1 carriers for
12 hours and stained with monoclonal antibodies against FoxP3 or
Tax (MI-73), and then analyzed by flow cytometry.
Statistical analysis
For in vitro experiments, multiple data comparisons were
performed using Student’s unpaired t-test. Statistical differences
in the incidence of T-cell lymphoma were analyzed using a
logrank test.
Supporting Information
Figure S1 Characterization of the transgene. (A) Schematic
structure of the transgene. (B) Copy numbers of the transgene in
each line were determined by Southern blot analysis. Serially
diluted plasmids, used to calculate the copy number, are shown on
the left side.
Found at: doi:10.1371/journal.ppat.1001274.s001 (0.35 MB TIF)
Figure S2 Histological analysis of the skin and lung of HBZ-Tg
mice. HE staining showed massive infiltration of lymphocytes in
HBZ-Tg line 9 and 12, but not in line 2. Immunohistochemical
staining revealed that only some of infiltrating lymphocytes were
FoxP3 positive. Arrows indicate FoxP3 positive cells.
Found at: doi:10.1371/journal.ppat.1001274.s002 (4.46 MB TIF)
Figure S3 Flow cytometric analysis of TCRb and TCR cd
expression in the spleen with lymphoma observed in HBZ-Tg
mice. Numbers are identical to those of Table 1.
Found at: doi:10.1371/journal.ppat.1001274.s003 (0.32 MB TIF)
Figure S4 PCR/single stranded conformation polymorphism
(SSCP) analysis. HBZ-Tg lymphoma tissue samples were analyzed
for TCR clonality using PCR-SSCP analysis of the TCR c-gene.
EL-4 are shown as a positive control and splenic DNA from young
(less than 6 weeks old) non-Tg or HBZ-Tg mice as a negative
control. Lanes 1- 5 (#2-3, #9-1, #12-6, #9-3, #12-7) show
lymphoma from HBZ-Tg mice respectively (Table 1).
Found at: doi:10.1371/journal.ppat.1001274.s004 (1.09 MB TIF)
Figure S5 Analysis of FoxP3 expression in fresh ATL cells.
Immunohistochemical staining for FoxP3 in the lymph nodes of
human ATL patients. We used a monoclonal antibody for human
FoxP3 (236A/E7; eBioscience).
Found at: doi:10.1371/journal.ppat.1001274.s005 (1.89 MB TIF)
Figure S6 Flow cytometric analysis of thymocyte subsets. Non-
Tg or HBZ-Tg thymocytes were stained with anti-CD4 and anti-
CD8 antibody, and then analyzed by flow cytometry.
Found at: doi:10.1371/journal.ppat.1001274.s006 (0.48 MB TIF)
Figure S7 Foxp3 expression in spleen, cervical lymph node, or
peripheral blood mononuclear cells was determined by flow
cyotmetry. Representative histograms gated on the CD4
+
population are shown.
Found at: doi:10.1371/journal.ppat.1001274.s007 (0.36 MB TIF)
Figure S8 HBZ-Tg line 2 also showed an increase in effector/
memory and regulatory CD4 T cells. Mouse splenocytes were
stained with antibodies for CD4 and CD8 plus CD44 and
CD62L (A) or CD25 and Foxp3 (B), and then analyzed by flow
cytometry. Representative dot plots gated on the CD4
+
population are shown.
Found at: doi:10.1371/journal.ppat.1001274.s008 (0.57 MB TIF)
Figure S9 IL-2 production of CD4
+ T cells in HBZ-Tg mice. (A)
Mouse splenocytes were stimulated with Leukocyte Activation
Cocktail, which contains PMA/Ionomycin and protein transport
inhibitor (BD Pharmingen), for 4 hours and then analyzed for
intracellular IL-2 gated on the CD4
+ cells by flow cytometry.
Representative results of more than three independent experi-
ments are shown. (B) The percentage of IL-2
+ cells among Foxp3
+
cells is shown. The results shown are the mean 6 SD of triplicate
experiments.
Found at: doi:10.1371/journal.ppat.1001274.s009 (0.26 MB TIF)
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tax-Tg splenocytes were stained with the indicated antibodies, and
analyzed by flow cytometry. Representative dot plots gated on the
CD4
+ population are shown.
Found at: doi:10.1371/journal.ppat.1001274.s010 (0.54 MB TIF)
Figure S11 The effect of HBZ on Foxp3/AML-1 complex. (A)
293FT-cells were co-transfected with vectors expressing the
indicated proteins, lysed, and subjected to immunoprecipitation.
(B) Jurkat cells were co-transfected with expression vectors for the
indicated proteins and IL-2 promoter-luc constructs. The results
shown are relative values of firely luciferase normalized to Renilla
luciferase and expressed as means 6 SD. The experiments were
repeated three times with similar results.
Found at: doi:10.1371/journal.ppat.1001274.s011 (0.37 MB TIF)
Figure S12 Characterization of the interaction between HBZ
and NFAT. To investigate the region responsible for each
interaction, we performed immunoprecipitation experiments with
NFATC2 and deletion mutants of HBZ. Asterisk shows the region
responsible for the molecular interaction.
Found at: doi:10.1371/journal.ppat.1001274.s012 (0.25 MB TIF)
Figure S13 The percentages of HTLV-1
+ T cells in
CD4
+FoxP3
2 and CD4
+FoxP3
+ subpopulations of asymptomatic
HTLV-1 carriers. It has been reported that ex vivo culture induces
the reactivation of viral antigen in HTLV-1 infected cells. We
cultured freshly isolated PBMC from two asymptomatic HTLV-1
carriers for 18 hours, and then stained intracellular Tax as a viral
antigen to detect the presence of HTLV-1 by using a monoclonal
antibody of Tax (MI-73).
Found at: doi:10.1371/journal.ppat.1001274.s013 (0.31 MB TIF)
Table S1 (A) Summary of BrdU incorporation in vivo. Data
shown are percentage of BrdU positive cells of three different non-
Tg or HBZ-Tg mice. (B) MFI of Treg associated molecules
(CTLA-4, GITR, CD103, or CCR4) in non-Tg or HBZ-Tg (line
12) mice are shown as mean 6 SD (n=3). of three mice.
*, P,0.05; **, P,0.01 by two-tailed Student t-test.
Found at: doi:10.1371/journal.ppat.1001274.s014 (0.25 MB TIF)
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